Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.
D002518:Ceramides / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism*; D002675:Child, Preschool; D002845:Chromatography; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D004952:Esters; D005227:Fatty Acids / Q000378:metabolism*; D005233:Fatty Alcohols / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006867:Hydrolases / Q000378:metabolism; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000378:metabolism; D007592:Joint Diseases / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D008064:Lipidoses / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D000432:Methanol; D008745:Methylation; D010859:Pigmentation Disorders / Q000378:metabolism; D012127:Respiratory Distress Syndrome, Newborn / Q000378:metabolism; D012825:Silicon
D002518:Ceramides; D004952:Esters; D005227:Fatty Acids; D005233:Fatty Alcohols; D006867:Hydrolases; D000432:Methanol; D012825:Silicon